Mironid
- Website
- mironid.com
- Total Funding
- $53.7M
- Last Round
- $41.3M Series ASep 2023
- Rounds
- 3
About
PDE4B inhibitor for inflammatory and fibrotic lung disease
Summary
It has raised $53.7M in total across 3 rounds, most recently a $41.3M Series A round in Sep 2023. Investors include Epidarex Capital, Sofinnova Partners and BioGeneration Ventures.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
$41.3M
Sep 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.